Pre-market Hot Trades in US Stocks

Tempus AI is down 7.59% in pre-market trading. Based on recent news,

1. On July 20, Tempus AI announced it would acquire Personalis at a price of $16.25 per share. This news raised market concerns, leading to a drop in stock price.

2. On July 17, analyst Matson pointed out that Personalis's stock price had recently outperformed the market, mainly due to investor expectations of a possible acquisition. The realization of this expectation led to fluctuations in Tempus AI's stock price.

3. On July 17, investors digested Tempus AI's first-quarter financial report. Although the company performed strongly in early 2025, its stock price has significantly retreated since then. The medical technology industry has been quite volatile recently, and investors should be cautious.

Top Gainers in Pre-market US Stocks

Baiya is up 78.50% in pre-market trading. There has been no significant news recently; trading is active, and capital flows are evident. Considering sector and industry trends, the stock shows significant volatility, and specific reasons need further observation. no_news

Sadot is up 30.43% in pre-market trading. Based on recent key news:

1. On July 17, Sadot reached a settlement agreement with Helena Global Investment, ending a legal dispute and terminating a $10 million equity credit line. This news drove the stock price up by 41%. Source: Zhitong Finance

2. On July 17, Sadot completed a $6 million acquisition of TradeIQ software assets, aimed at improving its capital structure and restoring compliance with Nasdaq's minimum shareholder equity requirements. This move had a positive impact on the stock price. Source: Zhitong Finance

3. On July 17, Sadot announced the launch of up to $100 million in senior secured convertible note financing to enhance liquidity and support growth plans. This news further propelled the stock price upward. Source: Zhitong Finance. Volatility in the commodities and agricultural products trading sector has intensified.

Advanced Biomed is up 27.24% in pre-market trading. Based on recent news,

1. On July 17, Advanced Biomed announced the termination of its purchase agreement with Helena Global Investment Opportunities I Ltd. The termination of this agreement will take effect on July 21, 2026. This news may have sparked positive market expectations regarding the company's future capital operations, driving the stock price up.

2. On July 17, Advanced Biomed filed an 8-K document detailing the relevant matters regarding the termination of the purchase agreement. Investors may view this move as helping the company operate its capital more flexibly, thereby boosting market confidence.

3. Recently, Advanced Biomed's technical sentiment signals indicated a sell, but the market reacted positively to the company's termination of the purchase agreement, leading to a significant rise in stock price The biopharmaceutical industry has been active recently, attracting high investor attention